Elevra (ELVR) adds 255,830 ASX shares from prior placement
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Elevra Limited has applied for quotation of 255,830 new ELV ordinary fully paid shares on the ASX, issued as part of a previously announced placement under an Appendix 3B. The shares were issued on 24 April 2026 at USD 6 per share.
After these shares are quoted, Elevra will have 169,632,601 ELV ordinary fully paid shares on issue. The capital structure also includes 2,708,166 ELVAM performance rights and 2,723,613 ELVAN options expiring 31 December 2028 with an exercise price of USD 4.80, which remain unquoted.
Positive
- None.
Negative
- None.
Key Figures
New shares quoted: 255,830 shares
Issue price: USD 6 per share
Total quoted shares: 169,632,601 shares
+2 more
5 metrics
New shares quoted
255,830 shares
ELV ordinary fully paid shares issued 24 April 2026
Issue price
USD 6 per share
Cash consideration for new ELV shares
Total quoted shares
169,632,601 shares
ELV ordinary fully paid on issue after quotation
Performance rights
2,708,166 rights
ELVAM performance rights, unquoted on ASX
Options outstanding
2,723,613 options
ELVAN options expiring 31-DEC-2028, exercise price USD 4.80
Key Terms
ORDINARY FULLY PAID, Appendix 3B, performance rights, option expiring 31-DEC-2028 EX $4.80, +2 more
6 terms
ORDINARY FULLY PAID financial
"ASX +security code and description ELV ORDINARY FULLY PAID"
Appendix 3B regulatory
"previously announced to the market in an Appendix 3B"
performance rights financial
"ELVAM PERFORMANCE RIGHTS | 2,708,166"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
option expiring 31-DEC-2028 EX $4.80 financial
"ELVAN OPTION EXPIRING 31-DEC-2028 EX $4.80 | 2,723,613"
placement financial
"A placement or other type of issue"
Placement is a company’s sale of new shares or bonds directly to a limited group of investors instead of offering them to the general public. It matters to investors because it raises cash for the company but can change the number of shares outstanding and the mix of owners, which can dilute existing holdings or signal management’s view of financing needs — like a bakery selling a private batch to a few cafes rather than opening it to all customers.
cash consideration financial
"Are the +securities being issued for a cash consideration? Yes"
Cash consideration is the actual money paid to buy a company, asset, or stake rather than payment in shares or other forms. For investors it matters because cash payments deliver immediate, certain value and affect the buyer’s and seller’s cash reserves and balance sheets—like selling a car for cash versus taking a trade-in, one side gets instant spending power while the other changes its liquidity and risk profile.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2026
Commission File Number 001-42819
ELEVRA LITHIUM LIMITED
(Translation of registrant’s name into English)
Level 3,
10 Eagle Street
Brisbane, Queensland 4000
Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
|
Form 20-F ☒
|
Form 40-F ☐
|
 |
Appendix 2A - Application for quotation of securities |
|
Announcement Summary
|
Entity name
ELEVRA LITHIUM LIMITED
Announcement Type
New announcement
Date of this announcement
Tuesday April 28, 2026
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
|
ASX +security
code
|
Security description
|
Number of +securities to
be quoted
|
Issue date
|
||
|
ELV
|
ORDINARY FULLY PAID
|
255,830
|
24/04/2026
|
||
Refer to next page for full details of the announcement
|
Appendix 2A - Application for quotation of securities |
|
Part 1 - Entity and announcement details
|
1.1 Name of entity
ELEVRA LITHIUM LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
|
1.2 Registered number type
|
Registration number
|
| ABN | 26091951978 |
1.3 ASX issuer code
ELV
1.4 The announcement is
New announcement
1.5 Date of this announcement
28/4/2026
|
Appendix 2A - Application for quotation of securities |
|
Part 2 - Type of Issue
|
2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
|
Announcement Date and
Time
|
Announcement Title
|
Selected Appendix 3B to submit quotation
request
|
|||
|
29-Aug-2025 15:14
|
New - Proposed issue of securities -SYA
|
A placement or other type of issue
|
|||
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
Yes
2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B
|
Legacy Piedmont Options granted and outstanding under the Piedmont Stock Incentive Plan may still be exercised. If exercised, these will be settled with Elevra ordinary, fully paid shares under the terms
of the Merger Agreement - refer to Notice of Meeting announcement released on 20 June 2025 for further details.
|
|
Appendix 2A - Application for quotation of securities |
|
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
|
Placement Details
ASX +security code and description
ELV : ORDINARY FULLY PAID
Issue date
24/4/2026
Distribution Schedule
Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new
+securities held by the recipients in each category.
|
Number of +securities held
|
Number of holders
|
Total percentage of +securities held
For example, to enter a value of 50%
please input as 50.00 |
|
1 - 1,000
|
%
|
|
|
1,001 - 5,000
|
%
|
|
|
5,001 - 10,000
|
%
|
|
|
10,001 - 100,000
|
%
|
|
|
100,001 and over
|
1
|
100.00 %
|
|
Appendix 2A - Application for quotation of securities |
Issue details
Number of +securities to be quoted
255,830
Are the +securities being issued for a cash consideration?
Yes
| In what currency is the cash consideration being paid? | What is the issue price per +security? |
| USD - US Dollar | USD 6.00000000 |
Any other information the entity wishes to provide about the +securities to be quoted
|
|
This Appendix 2A relates to Elevra Shares issued in settlement of vested and exercised Piedmont Equity Awards in connection with the Merger.
|
|
|
Appendix 2A - Application for quotation of securities |
|
Part 4 - Issued capital following quotation
|
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
|
ASX +security code and description
|
Total number of
+securities on issue
|
|
ELV : ORDINARY FULLY PAID
|
169,632,601
|
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
|
ASX +security code and description
|
Total number of
+securities on issue
|
|
ELVAM : PERFORMANCE RIGHTS
|
2,708,166
|
|
ELVAN : OPTION EXPIRING 31-DEC-2028 EX $4.80
|
2,723,613
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
ELEVRA LITHIUM LIMITED
|
|||
|
Date: April 30, 2026
|
By:
|
/s/ Dylan Roberts
|
|
|
Name: Dylan Roberts
|
|||
| Title: Company Secretary and General Counsel | |||
FAQ
What did Elevra Limited (ELVR) announce in its April 2026 filing?
Elevra Limited applied for ASX quotation of 255,830 new ordinary fully paid ELV shares. These shares were issued on 24 April 2026 as part of a previously announced placement under an Appendix 3B, expanding the company’s quoted share capital.
Does the Elevra (ELVR) filing mention any unquoted securities outstanding?
Yes. Elevra reports 2,708,166 ELVAM performance rights and 2,723,613 ELVAN options expiring 31 December 2028 with a USD 4.80 exercise price. These instruments are issued but remain unquoted on the ASX, forming part of the broader capital structure.
Will there be further Elevra (ELVR) securities issued under the same Appendix 3B?
Yes. The document confirms further issues of securities remain to occur to complete the transactions described in the earlier Appendix 3B. This means the 255,830 quoted shares are only one portion of the overall placement or issuance program previously outlined to the market.